Plain-English translation of NCT07547735 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a Phase II clinical trial testing —stem cells derived from umbilical cord tissue—as a treatment for knee osteoarthritis. Researchers believe these stem cells may help reduce inflammation, repair damaged cartilage, and ease the chronic pain that comes with worn joints. The study will compare the medication at two different doses against a placebo injection to see which approach works best.
Knee osteoarthritis affects over 1 billion people worldwide and currently has no cure—treatment mainly manages pain. This medication is being studied because laboratory research suggests stem cells can reduce joint inflammation and help cartilage regenerate, offering hope for a disease that causes lasting damage and disability.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive conventional pain management plus one injection directly into your knee joint. You will be randomly assigned to receive either the stem cell treatment at a lower dose, the stem cell treatment at a higher dose, or a placebo (salt solution). The study involves screening visits, the injection procedure, and follow-up visits to monitor your pain levels, knee function, and imaging results over time.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China